文献速递新生儿

新生儿高胆红素血症家庭光疗的评估

Evaluation of Home Phototherapy for Neonatal Hyperbilirubinemia.
PubMed 文献 · J Pediatr · 2020-02-14

这项回顾性研究纳入1385名≥35周新生儿中符合标准的1324名,评估综合家庭光疗(含每日哺乳支持和采血)。95%CI 1.3%-2.8%)需住院,住院与光疗开始日龄较小及总胆红素相对治疗阈值更高相关。

要点

  • 综合家庭光疗可成功治疗绝大多数新生儿高胆红素血症。
  • 家庭光疗期间或结束后24小时内住院率为1.9%(95%CI 1.3%-2.8%)。
  • 开始光疗日龄每大1天,住院风险降低(OR 0.63;95%CI 0.44-0.91)。

核心结论

  • 综合家庭光疗成功治疗了该队列中绝大多数婴儿的高胆红素血症。

研究设计与样本

  • 回顾性研究,纳入18个月期间出生胎龄≥35周并接受综合家庭光疗(含每日居家哺乳支持和采血)的新生儿。
  • 排除无出生日期或时间记录、开始治疗日龄>14天、或结合胆红素≥2 mg/dL(≥34.2 μmol/L)的婴儿。
  • 1385名婴儿中1324名符合纳入标准,主要结局为家庭光疗期间或结束后24小时内任何住院。

主要发现

  • 开始家庭光疗时,376名婴儿(28%)处于或高于美国儿科学会光疗阈值。
  • 住院与开始光疗时年龄较小相关(日龄每大1天OR 0.63;95%CI 0.44-0.91)。
  • 住院与开始光疗时总血清胆红素相对治疗阈值更高相关(每高于治疗阈值1 mg/dL,OR 1.71;95%CI 1.40-2.08)。

临床怎么用

  • 对于符合条件的新生儿高胆红素血症婴儿,综合家庭光疗是可考虑的治疗方式。
  • 开始光疗时日龄较小或总胆红素相对治疗阈值较高者住院风险增加,需加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize home phototherapy treatment for neonatal hyperbilirubinemia and assess the risk factors associated with the need for hospital admission during or after home phototherapy. STUDY DESIGN: This was a retrospective study of newborn infants born at ≥35 weeks of gestation who underwent comprehensive home phototherapy (that included daily in-home lactation support and blood draws) over an 18-month period. We excluded infants who lacked a recorded birth date or time, started treatment at age >14 days, or had a conjugated serum bilirubin level of ≥2 mg/dL (≥34.2 μmol/L). The primary study outcome was any hospital admission during or within 24 hours after completion of home phototherapy. Logistic regression was used to identify risk factors for hospitalization. RESULTS: Of the cohort of 1385 infants, 1324 met the inclusion criteria. At the time home phototherapy was initiated, 376 infants (28%) were at or above the American Academy of Pediatrics phototherapy threshold. Twenty-five infants required hospitalization (1.9%; 95% CI, 1.3%-2.8%). Hospital admission was associated with a younger age at phototherapy initiation (OR, 0.63 for each day older in age; 95% CI, 0.44-0.91) and a higher total serum bilirubin level relative to the treatment threshold at phototherapy initiation (OR, 1.71 for each 1 mg/dL above the treatment threshold; 95% CI, 1.40-2.08). CONCLUSIONS: Comprehensive home phototherapy successfully treated hyperbilirubinemia in the vast majority of the infants in this cohort.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Chang PW, Waite WM. Evaluation of Home Phototherapy for Neonatal Hyperbilirubinemia. J Pediatr. 2020. PMID: 32067781. doi:10.1016/j.jpeds.2020.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。